x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

James Riddle, MCSE, CIP, CPIA, CRQM

VP of Research Services & Strategic Consulting, Advarra

Prior to joining Advarra, James Riddle served as a leader of the human subject protection and animal care and use program at the Fred Hutchinson Cancer Research Center, one of the nation’s largest independent cancer research centers. In addition, he was an Association for the Accreditation of Human Research Protection Programs (AAHRPP) site visitor and was the vice president of operations and director of technology at another large central IRB. Riddle is also a faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research (PRIM&R); a member of the Clinical Trials Transformation Initiative (CTTI) Steering Committee; a board member of the Northwest Association for Biomedical Research (NWABR); and a leader of the Alliance for Clinical Research Excellence and Safety (ACRES) Site Accreditation & Standards Initiative (SASI) technology domain accreditation team.

James Riddle

Latest Posts by James

 
Blog

What Goes into a Charter for DSMB or Endpoint Adjudication?

This blog outlines the key elements of a DMC/EAC charter document, explaining its importance in conducting safe and compliant research.

Read Now
5 min. read
Read more
 
Blog

Clinical Endpoint Adjudication Committees: Not Just for “Endpoints”

This blog outlines critical events where EACs are used to look at more than just “endpoints” in clinical research.

Read Now
4 min. read
Read more
 
Blog

A Look at the Processes Behind Clinical Endpoint and Event Adjudication

Take a closer look at how and why we leverage proprietary, custom, and intelligent technology in our EAC program

Read Now
7 min. read
Read more
 
Blog

Why Device, Diagnostic, and Digital Therapeutic Research Needs Endpoint Adjudication

This blog outlines when a device clinical trial sponsor should engage an EAC or CEC to provide specific medical expertise & safety oversight.

Read Now
5 min. read
Read more
 
Blog

DMC vs EAC: What’s the Difference?

This blog outlines the requirements for each committee, what it does, and the critical roles each plays in keeping research participants safe.

Read Now
5 min. read
Read more
 
Info Sheet

Planned Emergency Research: Points to Consider

Download tips and considerations for sponsors and IRBs for next research project involving exception from informed consent (EFIC)

Read Now
Read more
 
White Paper

Planned Emergency Research and Exception from Informed Consent

This white paper outlines considerations for those involved in planning, designing, conducting or reviewing EFIC studies

Read Now
Read more
 
Podcast

James Riddle and Willie Muehlhausen Discuss Digital Technology and Virtual Data Collection in Clinical Research

In this episode, we discuss the growth of decentralized clinical trial technology and how IRBs evolved to account for technology advancements.

Listen Now
Read more
 
Webinar

Integrating Expert Opinions: Why Your Clinical Trial Needs an EAC

In this webinar, we discuss the role of independent endpoint adjudication committees, from charter creation through end of study closeout.

Watch Now
Read more
 
Blog

Reflections from Cell and Gene Meeting on the Mesa 2021

This blog recounts the 2021 Cell and Gene Meeting on the Mesa conference, including details on cell and gene therapy's growth and trajectory.

Read Now
4 min. read
Read more
 
Podcast

James Riddle and Barbara Schneider Delve into the Different Players Involved in Reviewing Clinical Research

In this podcast episode, we discuss the different clinical research oversight committees and functions to ensure the safety of participants.

Listen Now
Read more
 
Webinar

Do You Have Appropriate Oversight? Understanding the Role of DSMBs

Take a look at the role and function of independent DMCs from charter creation through interim data analysis to prepare your next trial.

Watch Now
Read more